Kaye J - Search Results

1

Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam.

Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Craig UL, Schellenberg GD, Galasko DR. Borenstein AR, et al. Among authors: kaye j. Neurology. 2007 May 22;68(21):1764-71. doi: 10.1212/01.wnl.0000262027.31623.b2. Neurology. 2007. PMID: 17515538

2

Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.

Payami H, Schellenberg GD, Zareparsi S, Kaye J, Sexton GJ, Head MA, Matsuyama SS, Jarvik LF, Miller B, McManus DQ, Bird TD, Katzman R, Heston L, Norman D, Small GW. Payami H, et al. Among authors: kaye j. Neurology. 1997 Aug;49(2):512-8. doi: 10.1212/wnl.49.2.512. Neurology. 1997. PMID: 9270587

3

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.

Zareparsi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, Nutt J, Bird T, Schellenberg G, Payami H. Zareparsi S, et al. Among authors: kaye j. Ann Neurol. 1997 Oct;42(4):655-8. doi: 10.1002/ana.410420417. Ann Neurol. 1997. PMID: 9382478

4

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Among authors: kaye j. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.

5

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L).

Bird TD, Nochlin D, Poorkaj P, Cherrier M, Kaye J, Payami H, Peskind E, Lampe TH, Nemens E, Boyer PJ, Schellenberg GD. Bird TD, et al. Among authors: kaye j. Brain. 1999 Apr;122 ( Pt 4):741-56. doi: 10.1093/brain/122.4.741. Brain. 1999. PMID: 10219785

6

Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Doody RS, et al. Among authors: kaye ja. Neurology. 2001 May 8;56(9):1154-66. doi: 10.1212/wnl.56.9.1154. Neurology. 2001. PMID: 11342679

7

HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease.

Zareparsi S, James DM, Kaye JA, Bird TD, Schellenberg GD, Payami H. Zareparsi S, et al. Among authors: kaye ja. Neurology. 2002 Mar 26;58(6):973-5. doi: 10.1212/wnl.58.6.973. Neurology. 2002. PMID: 11914421

8

Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease.

Haan MN, Jagust WJ, Galasko D, Kaye J. Haan MN, et al. Among authors: kaye j. Arch Neurol. 2002 Apr;59(4):588-93. doi: 10.1001/archneur.59.4.588. Arch Neurol. 2002. PMID: 11939893

9

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD. Montine TJ, et al. Among authors: kaye ja. Ann Neurol. 2002 Aug;52(2):175-9. doi: 10.1002/ana.10272. Ann Neurol. 2002. PMID: 12210787

10

Natural history of cognitive decline in the old old.

Howieson DB, Camicioli R, Quinn J, Silbert LC, Care B, Moore MM, Dame A, Sexton G, Kaye JA. Howieson DB, et al. Among authors: kaye ja. Neurology. 2003 May 13;60(9):1489-94. doi: 10.1212/01.wnl.0000063317.44167.5c. Neurology. 2003. PMID: 12743237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,584 results

Search Page

Filters